Novel peptide hydrogels demonstrate matrix-metalloproteinase properties for 3D lung cancer models, suggesting potential in drug testing.
Novel peptide hydrogelators with MMP-2 degradation properties were utilized to encapsulate A549 cells, thereby creating 3D lung cancer models for testing anticancer drugs.
No takes yet. Share an insight, caveat, or question.
Tarım et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: